Liaman Mamedova

625 total citations
12 papers, 538 citations indexed

About

Liaman Mamedova is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Liaman Mamedova has authored 12 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 9 papers in Molecular Biology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Liaman Mamedova's work include Adenosine and Purinergic Signaling (10 papers), Receptor Mechanisms and Signaling (7 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Liaman Mamedova is often cited by papers focused on Adenosine and Purinergic Signaling (10 papers), Receptor Mechanisms and Signaling (7 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Liaman Mamedova collaborates with scholars based in United States, South Korea and Russia. Liaman Mamedova's co-authors include Kenneth A. Jacobson, Stefano Costanzi, Zhan‐Guo Gao, Bhalchandra V. Joshi, Pedro Besada, Frédéric Marteau, Katrin Sak, Jung‐Sun Lee, Jean‐Marie Boeynaems and Yong‐Chul Kim and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and Organic & Biomolecular Chemistry.

In The Last Decade

Liaman Mamedova

12 papers receiving 528 citations

Peers

Liaman Mamedova
Aishe Chen United States
Xiao-duo Ji United States
Sabine Meis Germany
Lauren J. Murphree United States
Shlykov Sg Ukraine
Liaman Mamedova
Citations per year, relative to Liaman Mamedova Liaman Mamedova (= 1×) peers Pier Andrea Borea

Countries citing papers authored by Liaman Mamedova

Since Specialization
Citations

This map shows the geographic impact of Liaman Mamedova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liaman Mamedova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liaman Mamedova more than expected).

Fields of papers citing papers by Liaman Mamedova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liaman Mamedova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liaman Mamedova. The network helps show where Liaman Mamedova may publish in the future.

Co-authorship network of co-authors of Liaman Mamedova

This figure shows the co-authorship network connecting the top 25 collaborators of Liaman Mamedova. A scholar is included among the top collaborators of Liaman Mamedova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liaman Mamedova. Liaman Mamedova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Harden, T. Kendall, Kenneth A. Jacobson, Víctor E. Márquez, et al.. (2020). Human P2Y 6 Receptor:  Molecular Modeling Leads to the Rational Design of a Novel Agonist Based on a Unique Conformational Preference. Figshare. 1 indexed citations
3.
Jacobson, Kenneth A., Stefano Costanzi, Bhalchandra V. Joshi, et al.. (2006). Agonists and Antagonists for P2 Receptors. Novartis Foundation symposium. 276. 58–72. 44 indexed citations
4.
Gao, Zhan‐Guo, Heng T. Duong, Soo‐Kyung Kim, et al.. (2006). Orthogonal Activation of the Reengineered A3Adenosine Receptor (Neoceptor) Using Tailored Nucleoside Agonists. Journal of Medicinal Chemistry. 49(9). 2689–2702. 41 indexed citations
5.
Kim, Yong‐Chul, Jung‐Sun Lee, Katrin Sak, et al.. (2005). Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor. Biochemical Pharmacology. 70(2). 266–274. 81 indexed citations
6.
Jacobson, Kenneth A., Liaman Mamedova, Bhalchandra V. Joshi, Pedro Besada, & Stefano Costanzi. (2005). Molecular Recognition at Adenine Nucleotide (P2) Receptors in Platelets. Seminars in Thrombosis and Hemostasis. 31(2). 205–216. 12 indexed citations
7.
Besada, Pedro, Liaman Mamedova, Craig J. Thomas, Stefano Costanzi, & Kenneth A. Jacobson. (2005). Design and synthesis of new bicyclic diketopiperazines as scaffolds for receptor probes of structurally diverse functionality. Organic & Biomolecular Chemistry. 3(10). 2016–2016. 35 indexed citations
8.
Mamedova, Liaman, Valérie Capra, Maria Rosa Accomazzo, et al.. (2005). CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors. Biochemical Pharmacology. 71(1-2). 115–125. 71 indexed citations
9.
Costanzi, Stefano, Bhalchandra V. Joshi, Savitri Maddileti, et al.. (2005). Human P2Y6 Receptor:  Molecular Modeling Leads to the Rational Design of a Novel Agonist Based on a Unique Conformational Preference. Journal of Medicinal Chemistry. 48(26). 8108–8111. 66 indexed citations
10.
Gao, Zhan‐Guo, Liaman Mamedova, Susanna Tchilibon, Ariel S. Gross, & Kenneth A. Jacobson. (2004). 2,2′-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding. Biochemical Pharmacology. 68(2). 231–237. 27 indexed citations
11.
Costanzi, Stefano, Liaman Mamedova, Zhan‐Guo Gao, & Kenneth A. Jacobson. (2004). Architecture of P2Y Nucleotide Receptors:  Structural Comparison Based on Sequence Analysis, Mutagenesis, and Homology Modeling. Journal of Medicinal Chemistry. 47(22). 5393–5404. 125 indexed citations
12.
Gao, Zhan‐Guo, Lak Shin Jeong, Hyung Ryong Moon, et al.. (2003). Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moiety. Biochemical Pharmacology. 67(5). 893–901. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026